Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Other Products: In Vivo | Medtech Insight | HBW Insight | Pink Sheet | Generics Bulletin

Sign In

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Existing Subscriber? Sign in to continue reading.

New to Scrip? Start a free trial today!

Email
Share

Nanjing Immunophage Biotech Co. Ltd.

http://www.immunophage.com.cn/

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Chinese Gene And Cell Therapy, mRNA Developers Raise More Funds In March

Bookmark

10 Apr 2023
Analysis

By Dexter Yan

Roughly $130m was raised in eight biopharma financings in China over the past months that were backed by venture capital investors.

China Financing

See All

Company Information

Industry
Biotechnology
Pharmaceuticals

Other Names / Subsidiaries
- Nanjing Aimeifei Biomedical Technology Co. Ltd., Aimei Pharma

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Nanjing Immunophage Biotech Co. Ltd.

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice